| pubmed-article:17174090 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17174090 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:17174090 | lifeskim:mentions | umls-concept:C1366487 | lld:lifeskim |
| pubmed-article:17174090 | lifeskim:mentions | umls-concept:C1414141 | lld:lifeskim |
| pubmed-article:17174090 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
| pubmed-article:17174090 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:17174090 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:17174090 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17174090 | pubmed:dateCreated | 2007-2-19 | lld:pubmed |
| pubmed-article:17174090 | pubmed:abstractText | The structure-activity relationship of various N-acyl-Gly-, N-acyl-Sar-, and N-blocked-boroPro derivatives against three prolyl peptidases was explored. Several N-acyl-Gly- and N-blocked-boroPro compounds showed low nanomolar inhibitory activity against fibroblast activation protein (FAP) and prolyl oligopeptidase (POP) and selectivity against dipeptidyl peptidase-4 (DPP4). N-Acyl-Sar-boroPro analogs retained selectivity against DPP4 and potent POP inhibitory activity but displayed decreased FAP inhibitory activity. | lld:pubmed |
| pubmed-article:17174090 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17174090 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17174090 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17174090 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:17174090 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:17174090 | pubmed:author | pubmed-author:LawF KFK | lld:pubmed |
| pubmed-article:17174090 | pubmed:author | pubmed-author:WolfBeni BBB | lld:pubmed |
| pubmed-article:17174090 | pubmed:author | pubmed-author:SutherlinDanD | lld:pubmed |
| pubmed-article:17174090 | pubmed:author | pubmed-author:WiesmannChris... | lld:pubmed |
| pubmed-article:17174090 | pubmed:author | pubmed-author:QuanCliffordC | lld:pubmed |
| pubmed-article:17174090 | pubmed:author | pubmed-author:EdosadaConrad... | lld:pubmed |
| pubmed-article:17174090 | pubmed:author | pubmed-author:MayedaMarkM | lld:pubmed |
| pubmed-article:17174090 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17174090 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17174090 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:17174090 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17174090 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17174090 | pubmed:pagination | 1438-42 | lld:pubmed |
| pubmed-article:17174090 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:meshHeading | pubmed-meshheading:17174090... | lld:pubmed |
| pubmed-article:17174090 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17174090 | pubmed:articleTitle | Synthesis and structure-activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POP. | lld:pubmed |
| pubmed-article:17174090 | pubmed:affiliation | Department of Medicinal Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. | lld:pubmed |
| pubmed-article:17174090 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17174090 | lld:chembl |
